Status & Updates
September 28, 2017: The lawsuit filed against Quincy Bioscience by the FTC and New York Attorney General was dismissed due to the regulators’ apparent failure to show that the company lacks proper substantiation for its claims about Prevagen’s ability to improve memory, though the dismissal was without prejudice meaning regulators can refile their complaint.
January 10, 2017: The BBB changes its A+ rating of Quincy Bioscience to “No Rating.”
January 9, 2017: The FTC, together with the New York Attorney General, files a lawsuit against Quincy Bioscience for, among other things, falsely advertising Prevagen as able to improve memory.
After the filing of the lawsuit, TINA.org sends letters to the same five major TV networks it had notified in January 2016 (ABC, NBC, FOX, The Weather Channel, and Turner Broadcasting System) to notify them of the federal lawsuit filed against Quincy Bioscience and urging them to cease airing ads for Prevagen. TINA.org also sends a letter to the BBB notifying it of the lawsuit and urging it once again to re-evaluate its A+ rating of the company.
January 19, 2016: TINA.org sends letters to five major TV networks (ABC, NBC, FOX, The Weather Channel, and Turner Broadcasting System) that air Prevagen commercials putting them on notice that the commercials are deceptive and in violation of the networks’ own stated policies to only air truthful marketing.
TINA.org also sends a letter to the BBB calling on the organization to re-evaluate its A+ rating of Quincy Bioscience.
September 17, 2015: After getting no response from Quincy Bioscience, TINA.org sends a complaint letter to the FTC urging the agency to take action to halt the company’s deceptive marketing of Prevagen.
September 8, 2015: TINA.org sends a warning letter to Quincy Bioscience regarding its deceptive marketing campaign for Prevagen, and asking that the company correct the issues within one week.